Idorsia Stock: Likely Set For A Short Squeeze (OTCMKTS:IDRSF)
seekingalpha.com
finance
2022-05-27 17:15:48

Vertigo3d/E+ via Getty Images Investment Thesis Idorsia Ltd (OTCPK:IDRSF) has a very interesting setup where the fundamental value continues to increase. The company now has two products on the market, with one being likely a blockbuster candidate, and a third product licensed to Johnson & Johnson (JNJ) and commercialized in the U.S. and Europe. Its pipeline is filled with 11 compounds, among them at least another blockbuster candidate and many very promising compounds in different stages of development.
